Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AEOLUS PHARMACEUTICALS, INC. | 150,000 | reported | 08 Mar 2013 | tx 5+177,027 |
| ROCKWELL MEDICAL, INC. | 80,000 | reported | 09 Sept 2022 | tx 3+830,000 |
| ALIMERA SCIENCES INC | 50,000 | reported | 21 Nov 2023 | tx 4+178,000 |
| Lineage Cell Therapeutics, Inc. | 24,078 | reported | 18 Dec 2018 | tx 10+485,750−45,422 |
| Processa Pharmaceuticals, Inc. | 10,758 | reported | 29 May 2026 | tx 6+2,239,320 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 2,292 | 2.57 USD | |
| 15 May 2026 | PURCHASE | Processa Pharmaceuticals, Inc. | 1,984 | 2.97 USD | first after silence |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 324,000 | 0.00 USD | deriv |
| 01 Oct 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 108,000 | 0.00 USD | deriv |
| 24 Jul 2025 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 1,775,044 | 0.00 USD | deriv |
| 16 Jul 2024 | GRANT_AWARD | Processa Pharmaceuticals, Inc. | 28,000 | 0.00 USD | deriv |
| 21 Nov 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 50,000 | 0.00 USD | deriv |
| 26 Mar 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 58,000 | 0.00 USD | |
| 09 Jan 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 17,500 | 0.00 USD | |
| 09 Jan 2023 | GRANT_AWARD | ALIMERA SCIENCES INC | 52,500 | 0.00 USD | deriv |
| 09 Sept 2022 | GRANT_AWARD | ROCKWELL MEDICAL, INC. | 80,000 | 0.00 USD | deriv |
| 15 Sept 2020 | GRANT_AWARD | ROCKWELL MEDICAL, INC. | 600,000 | 0.00 USD | deriv |
| 15 Sept 2020 | GRANT_AWARD | ROCKWELL MEDICAL, INC. | 150,000 | 0.00 USD | deriv |
| 18 Dec 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 22,500 | 0.00 USD | |
| 18 Dec 2018 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 7,781 | 1.03 USD | |
| 18 Dec 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 22,500 | 0.00 USD | deriv |
| 04 Oct 2018 | TAX_WITHHOLDING | Lineage Cell Therapeutics, Inc. | 3,891 | 2.22 USD | |
| 04 Oct 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 11,250 | 0.00 USD | |
| 04 Oct 2018 | EXERCISE | Lineage Cell Therapeutics, Inc. | 11,250 | 0.00 USD | deriv |
| 15 Mar 2018 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 150,000 | 0.00 USD | deriv |
| 23 Aug 2017 | PURCHASE | Lineage Cell Therapeutics, Inc. | 2,000 | 2.64 USD | first after silence |
| 06 Jun 2017 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 250,000 | 0.00 USD | deriv |
| 08 Sept 2016 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 08 Mar 2013 | GRANT_AWARD | AEOLUS PHARMACEUTICALS, INC. | 150,000 | 0.00 USD | deriv |
| 23 May 2012 | PURCHASE | AEOLUS PHARMACEUTICALS, INC. | 7,027 | 0.24 USD | first after silence |
3 purchases reported after at least 12 months of silence — most recent on 15 May 2026.